These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2085 related articles for article (PubMed ID: 27406189)

  • 1. Tackling Threats and Future Problems of Multidrug-Resistant Bacteria.
    Medina E; Pieper DH
    Curr Top Microbiol Immunol; 2016; 398():3-33. PubMed ID: 27406189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Designing drugs that overcome antibacterial resistance: where do we stand and what should we do?
    Penchovsky R; Traykovska M
    Expert Opin Drug Discov; 2015 Jun; 10(6):631-50. PubMed ID: 25981754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antibiotic resistance crisis, with a focus on the United States.
    Martens E; Demain AL
    J Antibiot (Tokyo); 2017 May; 70(5):520-526. PubMed ID: 28246379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Future antibiotics scenarios: is the tide starting to turn?
    Theuretzbacher U
    Int J Antimicrob Agents; 2009 Jul; 34(1):15-20. PubMed ID: 19342202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidrug-Resistant Bacterial Infections in Solid Organ Transplant Candidates and Recipients.
    Bartoletti M; Giannella M; Tedeschi S; Viale P
    Infect Dis Clin North Am; 2018 Sep; 32(3):551-580. PubMed ID: 30146023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic resistance.
    Frieri M; Kumar K; Boutin A
    J Infect Public Health; 2017; 10(4):369-378. PubMed ID: 27616769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agents.
    Allahverdiyev AM; Kon KV; Abamor ES; Bagirova M; Rafailovich M
    Expert Rev Anti Infect Ther; 2011 Nov; 9(11):1035-52. PubMed ID: 22029522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbiological surveillance and antimicrobial stewardship minimise the need for ultrabroad-spectrum combination therapy for treatment of nosocomial infections in a trauma intensive care unit: an audit of an evidence-based empiric antimicrobial policy.
    Ramsamy Y; Muckart DJ; Han KS
    S Afr Med J; 2013 Mar; 103(6):371-6. PubMed ID: 23725954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisphosphocins: novel antimicrobials for enhanced killing of drug-resistant and biofilm-forming bacteria.
    Wong JP; DiTullio P; Parkinson S
    Future Microbiol; 2015; 10(11):1751-8. PubMed ID: 26597426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance to antibiotics: are we in the post-antibiotic era?
    Alanis AJ
    Arch Med Res; 2005; 36(6):697-705. PubMed ID: 16216651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostics and Resistance Profiling of Bacterial Pathogens.
    Hornischer K; Häußler S
    Curr Top Microbiol Immunol; 2016; 398():89-102. PubMed ID: 27474081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current and future challenges in the development of antimicrobial agents.
    Rennie RP
    Handb Exp Pharmacol; 2012; (211):45-65. PubMed ID: 23090595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies to prevent the occurrence of resistance against antibiotics by using advanced materials.
    Bassegoda A; Ivanova K; Ramon E; Tzanov T
    Appl Microbiol Biotechnol; 2018 Mar; 102(5):2075-2089. PubMed ID: 29392390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fighting infections due to multidrug-resistant Gram-positive pathogens.
    Cornaglia G
    Clin Microbiol Infect; 2009 Mar; 15(3):209-11. PubMed ID: 19335367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fosfomycin--its significance for treatment of diseases due to multidrug-resistant bacteria].
    Stock I
    Med Monatsschr Pharm; 2015 Jan; 38(1):4-11. PubMed ID: 26349119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New strategies for combating multidrug-resistant bacteria.
    Wright GD; Sutherland AD
    Trends Mol Med; 2007 Jun; 13(6):260-7. PubMed ID: 17493872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antimicrobial resistance and dissemination of multidrug resistant organisms-A review].
    Wang J; Wang X; Xu H
    Wei Sheng Wu Xue Bao; 2016 Nov; 56(11):1671-9. PubMed ID: 29741829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal infections due to multi-resistant strains: Epidemiology, current treatment, emerging therapeutic approaches and prevention.
    Tzialla C; Borghesi A; Pozzi M; Stronati M
    Clin Chim Acta; 2015 Dec; 451(Pt A):71-7. PubMed ID: 25749408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacterial genome engineering and synthetic biology: combating pathogens.
    Krishnamurthy M; Moore RT; Rajamani S; Panchal RG
    BMC Microbiol; 2016 Nov; 16(1):258. PubMed ID: 27814687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is screening patients for antibiotic-resistant bacteria justified in the Indian context?
    Bhattacharya S
    Indian J Med Microbiol; 2011; 29(3):213-7. PubMed ID: 21860099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 105.